M&A Deal Summary

Chiesi Farmaceutici Acquires Amryt Pharma

On January 8, 2023, Chiesi Farmaceutici acquired life science company Amryt Pharma for 1.5B USD

Acquisition Highlights
  • This is Chiesi Farmaceutici’s 4th transaction in the Life Science sector.
  • This is Chiesi Farmaceutici’s largest (disclosed) transaction.
  • This is Chiesi Farmaceutici’s 1st transaction in Ireland.

M&A Deal Summary

Date 2023-01-08
Target Amryt Pharma
Sector Life Science
Buyer(s) Chiesi Farmaceutici
Deal Type Add-on Acquisition
Deal Value 1.5B USD
Advisor(s) Moelis & Co. (Financial)
Cooley
Gibson, Dunn & Crutcher (Legal)

Target

Amryt Pharma

Dublin, Ireland
Amryt Pharma is a pharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of patients with rare and orphan diseases. Amryt Pharma is based in Dublin, Ireland.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Chiesi Farmaceutici

Parma, Italy

Category Company
Founded 1935
Sector Life Science
DESCRIPTION

Chiesi Farmaceutici is a research-focused international group, with more than 75 years of experience headquartered in Parma (Italy). Chiesi researches, develops and commercializes innovative pharmaceutical solutions in the respiratory therapeutics and specialist medicine areas.


DEAL STATS #
Overall 5 of 5
Sector (Life Science) 4 of 4
Type (Add-on Acquisition) 3 of 3
Country (Ireland) 1 of 1
Year (2023) 1 of 1
Size (of disclosed) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-05-23 Raptor Pharmaceuticals

Novato, California, United States

Raptor Pharmaceutical Corp. is a bio pharmaceutical company focused on the development and commercialization of transformative therapeutics for rare, debilitating and often fatal diseases. Raptor Pharmaceuticals Corp. was established in 2005 and is headquartered in Novato, California.

Buy $70M